Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹1000 | ₹100 |
Expense Ratio | 2.13 | 2.28 |
NAV | ₹14.15 | ₹145.01 |
Fund Started | 12 May 2023 | 13 Oct 2005 |
Fund Size | ₹1163.73 Cr | ₹1314.93 Cr |
Exit Load | Exit load of 1%, if redeemed within 15 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 0.03% | 9.70% |
3 Year | - | 17.50% |
5 Year | - | 23.81% |
1 Year
3 Year
5 Year
Equity | 99.50% | 92.74% |
Cash | -2.89% | 6.12% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Reliance Industries Ltd. | 10.62% |
ITC Ltd. | 9.83% |
HFCL Ltd. | 6.74% |
Samvardhana Motherson International Ltd. | 5.60% |
JIO Financial Services Ltd. | 5.46% |
S.P. Apparels Ltd. | 4.94% |
Aurobindo Pharma Ltd. | 4.92% |
Larsen & Toubro Ltd. | 4.64% |
Life Insurance Corporation of India | 4.55% |
Kovai Medical Center & Hospital Ltd. | 4.08% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 7.69% |
HDFC Bank Ltd. | 5.99% |
Reliance Industries Ltd. | 5.85% |
Bharti Airtel Ltd. | 5.54% |
Axis Bank Ltd. | 5.40% |
State Bank of India | 4.99% |
NTPC Ltd. | 4.61% |
Infosys Ltd. | 3.88% |
Larsen & Toubro Ltd. | 3.75% |
Sun Pharmaceutical Industries Ltd. | 3.29% |
Name | Ankit A Pande | Sri Sharma |
Start Date | 22 Aug 2023 | 30 Apr 2021 |
Name
Start Date
Description | The scheme seeks to generate long-term capital appreciation by investing with focus on riding business cycles through allocation between sectors and stocks at different stages of business cycles. | The scheme seeks to generate capital appreciation and income distribution to unit holders by investing predominantly in equity/equity related securities of the companies belonging to Exports & Services industry. |
Launch Date | 12 May 2023 | 13 Oct 2005 |
Description
Launch Date